Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
- Citation:
- J Clin Oncol vol 24 (25) 4196-201
- Year:
- 2006
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA076001
- Corr. Author:
- Authors:
- Wendy R Cornett Linda M McCall Rebecca P Petersen Merrick I Ross Henry A Briele R Dirk Noyes Jeffrey J Sussman William G Kraybill John M Kane H Richard Alexander Jeffrey E Lee Paul F Mansfield James F Pingpank David J Winchester Richard L White Vijaya Chadaram James E Herndon Douglas L Fraker Douglas S Tyler
- Networks:
- Study
- ACOSOG-Z0020
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Antineoplastic Agents, Alkylating, Chemotherapy, Cancer, Regional Perfusion, Extremities, Female, Humans, Hyperthermia, Induced, Male, Melanoma, Melphalan, Middle Aged, Patient Selection, Skin Neoplasms, Treatment Outcome, Tumor Necrosis Factor-alpha, United States